Cargando…

Effectiveness of Weekly Teriparatide Injection in Postmenopausal Patients with Hip Fractures

BACKGROUND: Teriparatide is an effective anabolic agent used in the treatment of severe osteoporosis. In addition, it is also used to promote fracture healing. The purpose of this double-blind randomized controlled trial was to evaluate the influence of weekly teriparatide administration on bone for...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lee, Sang Yeob, Seo, Min-Seok, Yoo, Jun-Il
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Korean Orthopaedic Association 2023
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10375812/ https://www.ncbi.nlm.nih.gov/pubmed/37529188 http://dx.doi.org/10.4055/cios22280

Ejemplares similares

The Effect of Teriparatide on the Hip: A Literature Review
por: Kim, Kwangkyoun, et al.
Publicado: (2021)

Teriparatide treatment for postmenopausal women with sacral insufficiency fracture
por: Kim, Young-Hoon
Publicado: (2023)

Reply on “teriparatide treatment for postmenopausal women with sacral insufficiency fracture”
por: Yang, Yao-Chun, et al.
Publicado: (2023)

Once-weekly teriparatide administration for 24 weeks in postmenopausal women with osteoporosis: reply to T. Kawada
por: Sugimoto, T., et al.
Publicado: (2014)

Effects of a single injection of teriparatide on bone turnover markers in postmenopausal women
por: Shiraki, M., et al.
Publicado: (2012)

Effect of weekly teriparatide injections on osteoporotic fracture healing: protocol for a double-blind, randomised controlled trial
por: Zhu, Junxiong, et al.
Publicado: (2021)

The effects of once-weekly teriparatide on hip structure and biomechanical properties assessed by CT
por: Ito, M., et al.
Publicado: (2013)

Study of twice-weekly injections of Teriparatide by comparing efficacy with once-weekly injections in osteoporosis patients: the TWICE study
por: Sugimoto, T., et al.
Publicado: (2019)

Profile of teriparatide in the management of postmenopausal osteoporosis
por: Sikon, Andrea, et al.
Publicado: (2010)

Weekly Teriparatide for Delayed Unions of Atypical Subtrochanteric Femur Fractures
por: Fukuda, Fumio, et al.
Publicado: (2014)

Effect of Artificial Intelligence or Machine Learning on Prediction of Hip Fracture Risk: Systematic Review
por: Cha, Yonghan, et al.
Publicado: (2023)

Profile of changes in bone turnover markers during once-weekly teriparatide administration for 24 weeks in postmenopausal women with osteoporosis
por: Sugimoto, T., et al.
Publicado: (2013)

Nonsurgical Corrective Union of Osteoporotic Vertebral Fracture with Once-Weekly Teriparatide
por: Miyakoshi, Naohisa, et al.
Publicado: (2015)

Effect of Teriparatide on Unstable Pertrochanteric Fractures
por: Huang, Tsan-Wen, et al.
Publicado: (2015)

Weekly teriparatide injections successfully treated advanced bisphosphonate-related osteonecrosis of the jaws
por: Yoshiga, D., et al.
Publicado: (2013)

Effect of Teriparatide on Healing of Atypical Femoral Fractures: A Systemic Review
por: Im, Gun-Il, et al.
Publicado: (2015)

Effects of Weekly Teriparatide Administration for Vertebral Stability and Bony Union in Patients with Acute Osteoporotic Vertebral Fractures
por: Kitaguchi, Kazuma, et al.
Publicado: (2019)

Efficacy of once-weekly and twice-weekly injections of teriparatide by patient characteristics: A post hoc analysis of the TWICE study
por: Sugimoto, Toshitsugu, et al.
Publicado: (2021)

Effect of Denosumab and Teriparatide on Fracture Nonunion
por: Boutin, Regine, et al.
Publicado: (2023)

Once-Weekly Injection of Low-Dose Teriparatide (28.2 μg) Reduced the Risk of Vertebral Fracture in Patients with Primary Osteoporosis
por: Fujita, Takuo, et al.
Publicado: (2013)

The effects of teriparatide and bisphosphonates on new fractures in postmenopausal women with osteoporosis: A protocol for systematic review and meta-analysis
por: Ouyang, YuLong, et al.
Publicado: (2021)

The impact of sequential therapy from short-term teriparatide to denosumab compared with denosumab alone in patients with osteoporotic hip fracture: a 1-year follow-up study
por: Park, Chan Ho, et al.
Publicado: (2020)

The Efficacy of Teriparatide in Improving Fracture Healing in Hip Fractures: A Systematic Review and Meta-Analysis
por: Han, Shuang, et al.
Publicado: (2020)

Teriparatide in Fracture Non-Unions
por: Coppola, C., et al.
Publicado: (2014)

Efficacy of weekly teriparatide does not vary by baseline fracture probability calculated using FRAX
por: Harvey, N. C., et al.
Publicado: (2015)

Effects of Teriparatide on Clinical and Radiologic Long-Term Outcomes after Fixation of Pertrochanteric Hip Fractures
por: Hosseini Khameneh, Mehdi, et al.
Publicado: (2023)

Cost-effectiveness of teriparatide compared with alendronate and risedronate for the treatment of postmenopausal osteoporosis patients in Iran
por: Ebadi Fard Azar, Amir Ali, et al.
Publicado: (2017)

Effect of teriparatide on quality of life in patients with postmenopausal osteoporosis: a retrospective cohort study
por: Yang, Tiansong, et al.
Publicado: (2019)

Hip and other fragility fracture incidence in real-world teriparatide-treated patients in the United States
por: Burge, R. T., et al.
Publicado: (2016)

Adjuvant Teriparatide Therapy for Surgical Treatment of Femoral Fractures; Does It Work?
por: Kim, Jung Taek, et al.
Publicado: (2016)

Unstable Bony Chance Fracture Successfully Treated With Teriparatide in Patient With Ankylosed Spine: A Case Report and Review of the Literature
por: Park, Hyung-Youl, et al.
Publicado: (2021)

Artificial intelligence and machine learning on diagnosis and classification of hip fracture: systematic review
por: Cha, Yonghan, et al.
Publicado: (2022)

Effects of Teriparatide on Treatment Outcomes in Osteoporotic Hip and Pelvic Bone Fractures: Meta-analysis and Systematic Review of Randomized Controlled Trials
por: Moon, Nam Hoon, et al.
Publicado: (2020)

The Effect of Teriparatide Treatment on the Risk of Fragility Fractures in Postmenopausal Women with Osteoporosis: Results from the Asian and Latin America Fracture Observational Study (ALAFOS)
por: Chen, Chung-Hwan, et al.
Publicado: (2021)

The cost effectiveness of teriparatide as a first-line treatment for glucocorticoid-induced and postmenopausal osteoporosis patients in Sweden
por: Murphy, Daniel R, et al.
Publicado: (2012)

Treatment responses with once-weekly teriparatide therapy for osteoporosis
por: Shiraki, M., et al.
Publicado: (2016)

Teriparatide in the Treatment of Severe Postmenopausal Osteoporosis: A Cost-Utility Analysis
por: Taheri, Saeed, et al.
Publicado: (2019)

Effectiveness of Osteoporosis Drug in Postmenopausal Women with Spinal Compression Fracture: Combined Consecutive Therapy of Teriparatide and Raloxifene versus Bisphosphonate Single
por: Shin, Chang Jin, et al.
Publicado: (2016)

Impact of patient background factors on the treatment efficacy of once-weekly teriparatide
por: Omura, Fumitoshi
Publicado: (2019)

Comparison of pharmacokinetics, pharmacodynamics, safety, and immunogenicity of teriparatide biosimilar with EU- and US-approved teriparatide reference products in healthy men and postmenopausal women
por: Fenwick, Steven, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_9es90euspc5qs0a71ljsjuccfb